60 DEGREES PHARMACEUTICALS, INC. — Form 8-K

60 Degrees Pharmaceuticals, Inc. (market cap ~$3.3M) has executed a form Securities Purchase Agreement (undated, effective July 2026) for a private placement of common stock and warrants. The agreement is a blank template with unfilled material terms: subscription amount, per-share price, warrant exercise prices, warrant percentages, and warrant terms are all bracketed placeholders. The Registration Rights Agreement requires Form S-3 registration within 15 days of closing, with effectiveness required by day 45–75. The agreement includes standard investor protections (legend removal, registration penalties of 2% monthly for public information failures, indemnification) and company restrictions (prohibition on variable-rate transactions for one year, equity issuance lockup for 30 days post-effective registration). No specific counterparties, share counts, dollar amounts, or closing date are disclosed.